Articles

Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?

Biogen is in focus today with the company's lecanemab drug set for an FDA decision on approval, leading to bullish bets on BIIB stock. More

7 Cheap Stocks That Wall Street Analysts Still Love

The number of cheap stocks Wall Street analysts love might have gone down over the past year, but there are still plenty of options. More

Is Ryan Cohen Going to Save Bed Bath & Beyond (BBBY) Stock?

Some investors in embattled retailer Bed Bath & Beyond and BBBY stock are pricing in the potential for Ryan Cohen to join the fray once again. More

7 Cheap Blue-Chip Stocks to Buy Before They Rebound

As stocks overall remain at depressed prices, now's the time to build long-term positions in these seven cheap blue-chip stocks. More

Why We’re Hopeful for the Market in 2023

Right now, we’re looking at a 0.15% gain on the week for the S&P 500. There are still 14 trading days left in the month, so a lot could go wrong… or right. More

5 Best Stocks to Buy if You Have $250 to Spend

These sector-leading companies have depressed stock prices that are a steal at their current levels. Investors should buy them on weakness. More

Are the Salesforce Layoffs Good or Bad for CRM Stock?

Salesforce (CRM) layoffs continue to be a hot topic with traders after the company announced a 10% reduction to its workforce. More